Related Experiment Video
Updated: Dec 31, 2025
06:08
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
3.5K
Current Perspectives on Delivery Systems Using Extracellular Vesicles in Neurological Disease
Phuong H L Tran1, Wei Duan1, Beom-Jin Lee2
1School of Medicine, Deakin University, Geelong, Australia.
Current Pharmaceutical Design
|January 3, 2020
Summary
Extracellular vesicles (EVs) show promise for treating neurological diseases due to their safety and targeting abilities. This review explores engineering EVs for effective therapeutic delivery, focusing on loading and modification strategies.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Drug Delivery Systems
Background:
- Extracellular vesicles (EVs) possess inherent capabilities for intercellular cargo transfer.
- Engineered EVs offer a promising platform for targeted delivery of therapeutic molecules.
- Compared to synthetic nanoparticles, EVs demonstrate superior safety and specificity for neurological disease treatment.
Purpose of the Study:
- To review the application of extracellular vesicles in delivering therapeutic factors for neurological diseases.
- To focus on the strategies for loading therapeutic molecules into EVs and modifying their surface.
- To support the development of advanced EV-based therapies for neurological conditions.
Main Methods:
- Review of existing literature on extracellular vesicle applications in neurological disease.
- Analysis of different types of extracellular vesicles and their modifications.
- Discussion of EV loading techniques and surface engineering strategies.
Main Results:
- Extracellular vesicles are safe and specific delivery vehicles for neurological therapies.
- Various strategies exist for loading natural and synthetic therapeutic molecules into EVs.
- Surface modification enhances EV targeting and therapeutic efficacy.
Conclusions:
- Extracellular vesicles represent a powerful platform for developing novel neurological therapies.
- Optimized EV loading and surface modification are crucial for therapeutic success.
- Further research in EV engineering will accelerate clinical translation for neurological disorders.
Keywords:
Extracellular vesiclesdelivery systemloadingneurological diseasespecificitytherapeutic molecules.More Related Videos
Related Concept Videos
01:36Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
01:29Drug Delivery: Parenteral Route
1.4K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.4K